Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Nov 1:216:108265.
doi: 10.1016/j.drugalcdep.2020.108265. Epub 2020 Aug 31.

Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids

Theresa Winhusen  1 , Christine Wilder  2 , Michael S Lyons  3 , Jeff Theobald  2 , Frankie Kropp  2 , Daniel Lewis  2
Affiliations
Randomized Controlled Trial

Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids

Theresa Winhusen et al. Drug Alcohol Depend. .

Abstract

Background: Opioid overdose prevention education and naloxone distribution (OEND) programs include information on general risk factors, overdose recognition, and naloxone utilization. This study evaluated a personally-tailored OEND (PTOEND) intervention designed to promote harm reduction and treatment readiness for illicit opioid users by also including education about personal overdose-risk factors and medication for opioid use disorder (MOUD).

Method: A secondary analysis of a randomized controlled trial testing a Peer recovery support service (PRSS) intervention, relative to Control, in adult illicit opioid users reporting treatment for an overdose in the prior 6 months. PTOEND, a 30-minute computer-guided intervention, was administered by a research assistant at the randomization visit to all participants (N = 80). Participants completed a telephone visit 3 weeks post-randomization (n = 74) to assess changes in opioid overdose/MOUD knowledge and treatment readiness. Participants completed in-person visits at 3 (n = 66), 6 (n = 58), and 12 (n = 44) months post-randomization to assess illicit opioid use and naloxone utilization (all time points) and overdose-risk behaviors (12 months). We conducted pre-post analyses of the impact of PTOEND controlling for the PRSS effect.

Results: PTOEND increased knowledge of overdose (79.8% to 81.5%, p < 0.05) and MOUD (66.9% to 75.0%, p < 0.01) and decreased perceived treatment barriers (2.1 to 1.9, p < 0.01); desire to quit all substances increased (7.2 to 7.8, p = 0.05). Self-reported opioid use was significantly decreased at each follow-up (all p < 0.01). Self-reported overdose-risk behaviors decreased significantly (6.2 to 2.4, p < 0.01). A majority of participants (65 %) reported naloxone utilization.

Conclusions: PTOEND may be effective for promoting harm reduction and treatment readiness.

Keywords: Harm reduction; Medication for opioid use disorder; Naloxone; Opioid; Overdose.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to report.

References

    1. Allen S.T., O’Rourke A., White R.H., Sherman S.G., Grieb S.M. Perspectives on fentanyl test strip use among people who inject drugs in Rural Appalachia. Subst. Use Misuse. 2020;55(10):1594–1600. - PubMed
    1. Bennett A.S., Bell A., Doe-Simkins M., Elliott L., Pouget E., Davis C. From peers to lay bystanders: findings from a decade of naloxone distribution in Pittsburgh, PA. J. Psychoactive Drugs. 2018;50(3):240–246. - PubMed
    1. Clark A.K., Wilder C.M., Winstanley E.L. A systematic review of community opioid overdose prevention and naloxone distribution programs. J. Addict. Med. 2014;8(3):153–163. - PubMed
    1. Fals-Stewart W., O’Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psych. 2000;68(1):134–144. - PubMed
    1. Goldman J.E., Waye K.M., Periera K.A., Krieger M.S., Yedinak J.L., Marshall B.D.L. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct. J. 2019;16(1) 3-3. - PMC - PubMed

Publication types

MeSH terms